Cost-Effectiveness of ICDs for MADIT-II–Eligible Patients
Hugh G Calkins · Journal watch · 2005
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Journal watch · Massachusetts Medical Society · article · 2005
Abstract
In the MADIT-II trial, implantable cardioverter-defibrillators (ICDs) improved survival by 31% in patients with LV ejection fractions ≤30% and
Open the resolved locator · 10.1056/jc200506100000003
Metadata licence: OpenAlex metadata (CC0)